alosetron and fluoxetine

alosetron has been researched along with fluoxetine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Keserü, GM	1
Nagashima, R; Nishikawa, T; Tobita, M	1
Jia, L; Sun, H	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
D'Souza, DL; Dimmitt, DC; Koch, KM; Nezamis, J; Robbins, DK; Simms, L	1
France, M; Galligan, JJ; Kadrofske, M; Skorich, E; Swain, GM	1

Reviews

1 review(s) available for alosetron and fluoxetine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for alosetron and fluoxetine

Article	Year
Effect of alosetron on the pharmacokinetics of fluoxetine. Journal of clinical pharmacology, 2001, Volume: 41, Issue:4 Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Biological Availability; Carbolines; Colon; Colonic Diseases, Functional; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Genotype; Half-Life; Humans; Isoenzymes; Male; Metabolic Clearance Rate; Middle Aged; Serotonin Antagonists; Time Factors	2001

Article

Year

Effect of alosetron on the pharmacokinetics of fluoxetine.

Journal of clinical pharmacology, 2001, Volume: 41, Issue:4

Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Biological Availability; Carbolines; Colon; Colonic Diseases, Functional; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Genotype; Half-Life; Humans; Isoenzymes; Male; Metabolic Clearance Rate; Middle Aged; Serotonin Antagonists; Time Factors

2001

Other Studies

4 other study(ies) available for alosetron and fluoxetine

Article	Year
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16 Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship	2003
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11 Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated	2005
Support vector machines classification of hERG liabilities based on atom types. Bioorganic & medicinal chemistry, 2008, Jun-01, Volume: 16, Issue:11 Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve	2008
Sex-related differences in small intestinal transit and serotonin dynamics in high-fat-diet-induced obesity in mice. Experimental physiology, 2016, Volume: 101, Issue:1 Topics: Animals; Carbolines; Diet, High-Fat; Female; Fluoxetine; Gastrointestinal Transit; Intestine, Small; Jejunum; Male; Mice; Mice, Inbred C57BL; Obesity; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Sex Characteristics	2016